Krystal Biotech Inc.

KRYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$333.85

-$2.82 (-0.84%)

At close: Sep 21, 2026, 4:00 PM ET

$333.85

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
PE Ratio	34.82	50.21	310.15	-14.43	-22.35	-35.09
PEG Ratio	0.27	0.07	-2.89	-0.19	-0.27	-0.83
PS Ratio	18.34	15.42	66.45	n/a	n/a	n/a
PB Ratio	5.85	4.73	4.33	3.87	2.62	3.86
P/FCF Ratio	37.77	37.58	-33.49	-13.15	-13.35	-27.54
P/OCF Ratio	35.53	36.29	-37.93	-20.08	-32.39	-43.22
OCF/S Ratio	51.62	42.48	-175.16	n/a	n/a	n/a
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.04
Quick Ratio	9.56	7.02	17.55	13.30	17.18	17.80
Current Ratio	9.95	7.28	17.76	13.30	17.18	17.80
Asset Turnover	0.29	0.28	0.06	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	-45.76	n/a
Return on Equity	16.80%	9.42%	1.40%	-26.80%	-11.72%	-11.01%
Return on Assets	15.36%	8.44%	1.34%	-25.06%	-11.11%	-10.35%
Return on Invested Capital	13.09%	6.43%	-11.82%	-27.34%	-11.35%	-10.87%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	92.61%	93.09%	93.90%	n/a	n/a	n/a
Net Profit Margin	52.64%	30.69%	21.56%	n/a	n/a	n/a
Pretax Profit Margin	48.69%	32.82%	25.44%	n/a	n/a	n/a
Operating Profit Margin	41.45%	22.61%	-216.43%	n/a	n/a	n/a
FCF Margin	48.55%	41.02%	-198.43%	n/a	n/a	n/a
EBITDA Margin	50.37%	37.83%	-180.11%	n/a	n/a	n/a